phosphatidylcholines has been researched along with az 11645373 in 1 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (az 11645373) | Trials (az 11645373) | Recent Studies (post-2010) (az 11645373) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 22 | 0 | 16 |
| Protein | Taxonomy | phosphatidylcholines (IC50) | az 11645373 (IC50) |
|---|---|---|---|
| P2X purinoceptor 7 | Homo sapiens (human) | 0.031 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bochkov, VN; Godschachner, V; Oskolkova, OV | 1 |
1 other study(ies) available for phosphatidylcholines and az 11645373
| Article | Year |
|---|---|
Off-Target Anti-Inflammatory Activity of the P2X7 Receptor Antagonist AZ11645373.
Topics: Anti-Inflammatory Agents; Human Umbilical Vein Endothelial Cells; Humans; Inflammasomes; Interleukin-8; Phosphatidylcholines; Purinergic P2X Receptor Antagonists; Receptors, Purinergic P2X7; RNA, Messenger; Thiazoles; Transcriptional Activation | 2017 |